s.zamora

TL2 · Nairobi

Contributes reviews on supplier material. Based in Nairobi.

Joined 20 November 2024 · last posted 2d

70Posts here

2Topics

1Solutions

1.3kLikes received

1.9kLikes given

21Badges

229Days visited

4.6kPosts read

Recent activity

Full stream

Reading a home test result without over-claiming Replied, post #135 · Analytics › Home & field testing · 25 Jul 2026 · 0 likes Post #134 put the caveat in the right place and I want to underline it. The right question for any home test is: what physical quantity does it measure, and what would…
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #16 · Compounds › Tirzepatide · 15 Jul 2026 · 21 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
What a certificate commits its issuer to Replied, post #20 · Analytics › COA interpretation · 12 Jul 2026 · 4 likes Everything in post #18 holds. The case it does not cover is the one I have. A chromatogram supplied as a small image is legible for peak shape and not for baseline…
Coming back to: A structured critique template this community uses Replied, post #46 · Evidence › Study critique · 30 Jun 2026 · 2 likes Structured critique template was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #7 · Analytics › Impurities & related substances · 17 Jun 2026 · 14 likes I read post #4 twice before replying, because I had assumed the opposite. The related-substances total is only as informative as the method that generated it. Two per…
Follow-up: An emergency department visit, described afterwards Replied, post #5 · Safety › Adverse events · 16 Jun 2026 · 6 likes Gallbladder symptoms during rapid weight loss are described in this class and are also associated with rapid weight loss generally. Both can be true.
Injecting into an area that has become firm: why not to Replied, post #71 · Practice › Administration · 14 Jun 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
[2026 update] Why 99.2% and 97.8% on the same lot can both be correct Replied, post #3 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 0 likes Small methodological point on 99.2% and 97.8%: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Does dual agonism explain the effect size, or is it dose? Replied, post #29 · Compounds › Tirzepatide · 11 Jun 2026 · 15 likes Coming back to post #26, because the follow-up matters more than the original answer. SURMOUNT-4's randomised withdrawal design is the strongest available evidence…
Micronutrient adequacy at low total intake Replied, post #42 · Nutrition & Training › Protein & intake · 9 Jun 2026 · 20 likes Micronutrient adequacy becomes a real question at very low total intake and is much less discussed than protein.
What a certificate commits its issuer to — the long version Replied, post #11 · Analytics › COA interpretation · 31 May 2026 · 0 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. A certificate of analysis is a statement by its issuer that a defined test was…
A single out-of-range value on an otherwise normal panel Replied, post #49 · Clinical › Bloodwork · 21 May 2026 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. That has…